F. O’Malley

639 total citations
9 papers, 476 citations indexed

About

F. O’Malley is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, F. O’Malley has authored 9 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in F. O’Malley's work include Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (3 papers) and Cancer therapeutics and mechanisms (2 papers). F. O’Malley is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Estrogen and related hormone effects (3 papers) and Cancer therapeutics and mechanisms (2 papers). F. O’Malley collaborates with scholars based in Canada, United Kingdom and United States. F. O’Malley's co-authors include E. A. Strom, D. David Dershaw, Monica Morrow, L W Bassett, Barbara Fowble, S. Eva Singletary, Stuart J. Schnitt, David P. Winchester, Jay R. Harris and A E Giuliano and has published in prestigious journals such as Journal of Clinical Oncology, CA A Cancer Journal for Clinicians and Breast Cancer Research and Treatment.

In The Last Decade

F. O’Malley

8 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. O’Malley Canada 6 332 223 209 136 90 9 476
Lajos Pusztai United States 5 407 1.2× 201 0.9× 240 1.1× 167 1.2× 87 1.0× 5 503
A. Helen Westenberg Netherlands 11 334 1.0× 220 1.0× 189 0.9× 179 1.3× 59 0.7× 19 520
George Papadatos Australia 8 360 1.1× 261 1.2× 168 0.8× 102 0.8× 103 1.1× 15 505
L.J. Pierce United States 6 319 1.0× 159 0.7× 183 0.9× 113 0.8× 83 0.9× 18 399
Claire Buchanan United States 8 301 0.9× 153 0.7× 226 1.1× 196 1.4× 85 0.9× 10 495
Amy Cyr United States 16 420 1.3× 178 0.8× 281 1.3× 246 1.8× 98 1.1× 46 607
Meghan Butler United States 5 252 0.8× 130 0.6× 136 0.7× 158 1.2× 50 0.6× 7 388
Cristina Olcese United States 11 316 1.0× 148 0.7× 236 1.1× 123 0.9× 75 0.8× 17 437
I. Raoust France 10 321 1.0× 282 1.3× 164 0.8× 111 0.8× 128 1.4× 22 546
Gabriela Gohla Canada 9 263 0.8× 90 0.4× 157 0.8× 60 0.4× 78 0.9× 15 363

Countries citing papers authored by F. O’Malley

Since Specialization
Citations

This map shows the geographic impact of F. O’Malley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. O’Malley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. O’Malley more than expected).

Fields of papers citing papers by F. O’Malley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. O’Malley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. O’Malley. The network helps show where F. O’Malley may publish in the future.

Co-authorship network of co-authors of F. O’Malley

This figure shows the co-authorship network connecting the top 25 collaborators of F. O’Malley. A scholar is included among the top collaborators of F. O’Malley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. O’Malley. F. O’Malley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
O’Malley, F., Stephen Chia, Dongsheng Tu, et al.. (2011). Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial. Breast Cancer Research and Treatment. 128(2). 401–409. 35 indexed citations
2.
Freedman, Orit, Eitan Amir, Wedad Hanna, et al.. (2009). A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer. Breast Cancer Research and Treatment. 119(1). 155–161. 12 indexed citations
3.
4.
5.
Hanna, Wedad, F. O’Malley, Penny J. Barnes, et al.. (2007). Updated Recommendations from the Canadian National Consensus Meeting on HER2/neu Testing in Breast Cancer. Current Oncology. 14(4). 149–153. 50 indexed citations
6.
O’Malley, F., Stephen Chia, Dongsheng Tu, et al.. (2006). Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5). Journal of Clinical Oncology. 24(18_suppl). 533–533. 26 indexed citations
7.
Morrow, Monica, E. A. Strom, L W Bassett, et al.. (2002). Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma. CA A Cancer Journal for Clinicians. 52(5). 277–300. 237 indexed citations
8.
Morrow, Monica, E. A. Strom, L W Bassett, et al.. (2002). Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS). CA A Cancer Journal for Clinicians. 52(5). 256–276. 110 indexed citations
9.
Singhal, Hemant, et al.. (1997). Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.. PubMed. 40(5). 377–82. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lajos Pusztai Breakdown of academic impact, for papers by A. Helen Westenberg Breakdown of academic impact, for papers by George Papadatos Breakdown of academic impact, for papers by L.J. Pierce Breakdown of academic impact, for papers by Claire Buchanan Breakdown of academic impact, for papers by Amy Cyr Breakdown of academic impact, for papers by Meghan Butler Breakdown of academic impact, for papers by Cristina Olcese Breakdown of academic impact, for papers by I. Raoust Breakdown of academic impact, for papers by Gabriela Gohla
Rankless by CCL
2026